AbTherx is advancing medicine with revolutionary technologies that accelerate and enable therapeutic antibody discovery. Through an exclusive partnership with Gilead Sciences, AbTherx has released Atlas™ Mice, a suite of novel transgenic technologies designed for unmatched performance and FTO. For over 20 years, AbTherx’s passionate, innovative, and collaborative team has pushed the boundaries of antibody discovery technologies, leading to over 1,000 successful antibody discovery campaigns and 13 marketed therapeutics. AbTherx’s industry-leading team creates transformative solutions to overcome the most demanding challenges in delivering innovative medicines. Committed to making its technologies accessible to all, AbTherx offers flexible partnering models that meet the needs of drug developers of all sizes.

Biotechnology

Life Sciences

Therapeutics

AbTherx

AbTherx's headquarters in Mountain View, United States

Justin Mika

Abhi Saharia

Stacey Borders

David Passmore

Peter Brams

Dan Rohrer

Brian Conn

This department focuses on the research and development of antibodies for various applications.

Antibody Discovery

This department oversees the strategic direction and management of preclinical research and intellectual property initiatives.

Research and Development

This department provides expert guidance and insights on scientific developments and strategies.

AbTherx

Org chart

Teams

Antibody Discovery

Research and Development

Scientific Advisory

Offices

AbTherx

Org chart

Teams

Antibody Discovery

Research and Development

Scientific Advisory

Offices

Related companies